The Pathoimmunobiology and Translational Implications of Targeting the PD-1 Checkpoint in Metastatic Cutaneous Squamous Cell Carcinoma (CSCC)

The Pathoimmunobiology and Translational Implications of Targeting the PD-1 Checkpoint in Metastatic Cutaneous Squamous Cell Carcinoma (CSCC)


Published

November 19, 2018

Created by

CMEducation Resources symposium

Related Presenters

Nikhil Khushalani, MD

Nikhil Khushalani, MD

Chief, Medical Oncology

Vice Chair and Associate Member, Cutaneous Oncology
H. Lee Moffitt Cancer Center, Tampa, FL
Associate Professor, USF MorsaniCollege of Medicine